These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 9303259)

  • 21. Continuous brachial plexus blockade in combination with the NMDA receptor antagonist memantine prevents phantom pain in acute traumatic upper limb amputees.
    Schley M; Topfner S; Wiech K; Schaller HE; Konrad CJ; Schmelz M; Birbaumer N
    Eur J Pain; 2007 Apr; 11(3):299-308. PubMed ID: 16716615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Motor cortex stimulation for the treatment of refractory peripheral neuropathic pain.
    Lefaucheur JP; Drouot X; Cunin P; Bruckert R; Lepetit H; Créange A; Wolkenstein P; Maison P; Keravel Y; Nguyen JP
    Brain; 2009 Jun; 132(Pt 6):1463-71. PubMed ID: 19336459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dorsal root entry zone lesions (Nashold's procedure) for pain relief following brachial plexus avulsion.
    Thomas DG; Sheehy JP
    J Neurol Neurosurg Psychiatry; 1983 Oct; 46(10):924-8. PubMed ID: 6644316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long term follow-up results of dorsal root entry zone lesions for intractable pain after brachial plexus avulsion injuries.
    Chen HJ; Tu YK
    Acta Neurochir Suppl; 2006; 99():73-5. PubMed ID: 17370768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sympatholysis after neuron-specific, N-type, voltage-sensitive calcium channel blockade: first demonstration of N-channel function in humans.
    McGuire D; Bowersox S; Fellmann JD; Luther RR
    J Cardiovasc Pharmacol; 1997 Sep; 30(3):400-3. PubMed ID: 9300326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological characterisation of the rat brachial plexus avulsion model of neuropathic pain.
    Rodrigues-Filho R; Campos MM; Ferreira J; Santos AR; Bertelli JA; Calixto JB
    Brain Res; 2004 Aug; 1018(2):159-70. PubMed ID: 15276874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ziconotide, an intrathecally administered N-type calcium channel antagonist for the treatment of chronic pain.
    Wermeling DP
    Pharmacotherapy; 2005 Aug; 25(8):1084-94. PubMed ID: 16207099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrathecal morphine delivered via subcutaneous pump for intractable pain in pancreatic cancer.
    Gilmer-Hill HS; Boggan JE; Smith KA; Frey CF; Wagner FC; Hein LJ
    Surg Neurol; 1999 Jan; 51(1):6-11. PubMed ID: 9952116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ziconotide: can we use it in palliative care?
    Prommer EE
    Am J Hosp Palliat Care; 2005; 22(5):369-74. PubMed ID: 16225359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Cav2.3 calcium channel antagonist SNX-482 reduces dorsal horn neuronal responses in a rat model of chronic neuropathic pain.
    Matthews EA; Bee LA; Stephens GJ; Dickenson AH
    Eur J Neurosci; 2007 Jun; 25(12):3561-9. PubMed ID: 17610575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microcoagulation of junctional dorsal root entry zone is effective treatment of brachial plexus avulsion pain: long-term follow-up study.
    Prestor B
    Croat Med J; 2006 Apr; 47(2):271-8. PubMed ID: 16625692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential blockade of voltage-sensitive calcium channels at the mouse neuromuscular junction by novel omega-conopeptides and omega-agatoxin-IVA.
    Bowersox SS; Miljanich GP; Sugiura Y; Li C; Nadasdi L; Hoffman BB; Ramachandran J; Ko CP
    J Pharmacol Exp Ther; 1995 Apr; 273(1):248-56. PubMed ID: 7714772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Chronic intrathecal drug administration for the control of intractable pain].
    Taira T
    Brain Nerve; 2008 May; 60(5):509-17. PubMed ID: 18516973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroprotection in the rat lateral fluid percussion model of traumatic brain injury by SNX-185, an N-type voltage-gated calcium channel blocker.
    Lee LL; Galo E; Lyeth BG; Muizelaar JP; Berman RF
    Exp Neurol; 2004 Nov; 190(1):70-8. PubMed ID: 15473981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of pain in brachial plexus lesions.
    Frampton V
    J Hand Ther; 1996; 9(4):339-43. PubMed ID: 8994008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitochondrial dysfunction after experimental and human brain injury and its possible reversal with a selective N-type calcium channel antagonist (SNX-111).
    Verweij BH; Muizelaar JP; Vinas FC; Peterson PL; Xiong Y; Lee CP
    Neurol Res; 1997 Jun; 19(3):334-9. PubMed ID: 9192388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clinical characteristics of neuropathic pain in patients with total brachial plexus avulsion: A 30-case study.
    Zhou Y; Liu P; Rui J; Zhao X; Lao J
    Injury; 2016 Aug; 47(8):1719-24. PubMed ID: 27287738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of the binding of omega-conopeptides to different classes of non-L-type neuronal calcium channels.
    Kristipati R; Nádasdi L; Tarczy-Hornoch K; Lau K; Miljanich GP; Ramachandran J; Bell JR
    Mol Cell Neurosci; 1994 Jun; 5(3):219-28. PubMed ID: 8087420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of refractory pain after brachial plexus avulsion with dorsal root entry zone lesions.
    Samii M; Bear-Henney S; Lüdemann W; Tatagiba M; Blömer U
    Neurosurgery; 2001 Jun; 48(6):1269-75; discussion 1275-7. PubMed ID: 11383729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calcium channel antagonist peptides define several components of transmitter release in the hippocampus.
    Gaur S; Newcomb R; Rivnay B; Bell JR; Yamashiro D; Ramachandran J; Miljanich GP
    Neuropharmacology; 1994 Oct; 33(10):1211-9. PubMed ID: 7862257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.